KDM5D

Overview

KDM5D (Lysine Demethylase 5D, also known as JARID1D) encodes a histone H3 lysine 4 (H3K4) trimethylation demethylase located on the Y chromosome. It is a recurrently deleted gene in cholangiocarcinoma and is catalogued among Y-chromosome-linked tumor suppressors. Loss of KDM5D alters the H3K4me3 chromatin landscape, potentially de-repressing oncogenic transcriptional programs.

Alterations observed in the corpus

  • Recurrent deletion in cholangiocarcinoma (n=16 deletions by WGS), making it one of the most frequently deleted genes in the CCA cohort PMID:28667006

Cancer types (linked)

  • Cholangiocarcinoma (CCA): Among the most recurrently deleted genes (n=16) by whole-genome sequencing across a multi-center CCA cohort PMID:28667006

Co-occurrence and mutual exclusivity

  • Co-deleted with UTY (n=17 deletions) and CDKN2A (n=17 deletions) in the same CCA cohort, consistent with Y-chromosome arm deletion events PMID:28667006

Therapeutic relevance

  • Loss of KDM5D may produce H3K4me3 landscape alterations targetable by epigenetic strategies; no clinical-grade KDM5D-directed therapy has been validated.

Open questions

  • Whether KDM5D deletion co-segregates with specific CCA molecular subtypes (Clusters 1–4) and whether it is an independent driver or passenger of Y-chromosome arm loss remains to be determined.

Sources

This page was processed by entity-page-writer on 2026-05-15.